Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies LAV Biosciences Fund V, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SR ONE CAPITAL MANAGEMENT, LLC - $27.20M in ADRX purchases and sales in the last 12 months
- Simeon George - $27.20M in ADRX purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $16.15M in ADRX purchases and sales in the last 12 months
- Carl L. Gordon - $16.15M in ADRX purchases and sales in the last 12 months
- Erez Chimovits - $1.05M in ADRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is LAV Biosciences Fund V, L.P.?
LAV Biosciences Fund V, L.P. is an investment firm, tracked as 10% Owner of ADARx Pharmaceuticals, Inc. (ADRX). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has LAV Biosciences Fund V, L.P. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
